SGLT2 inhibitors attenuate endothelial to mesenchymal transition and cardiac fibroblast activation
Article in Scientific Reports (July 2024)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
Sodium glucose transporter 2 inhibitors: Will these drugs benefit non‐diabetic veterinary patients with cardiac and kidney diseases?
Article in Journal of Veterinary Pharmacology and Therapeutics (July 2024)
SGLT-2 inhibitors as novel treatments of multiple organ fibrosis
Article in Heliyon (April 2024)